Series B

Oxular eyes $37m round
Hovione Scientia and Consort Medical-backed Oxular has secured funding that will support phase 2 trials for a treatment for diabetic macular oedema.
Carisma charms its way to $59m
Penn Medicine contributed to a $12m extension for the cancer immunotherapy developer's series B round, which already inlcuded Livzon, Merck & Co and AbbVie.
Armorblox stocks up with $30m
Siemens' Next47 unit led a series B round for the email security platform developer, increasing its total funding to more than $46m.
Artiva cleaves $120m in series B round
GC and its GC LabCell subsidiary both contributed to a round that will help advance the cancer immunotherapy developer's NK cell drug pipeline.
Corporate venturing deal net: 22-26 February 2021
Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.
Mosa Meat musters $85m in series B
The cultured meat product developer has added a $10m tranche of funding to its series B round from investors including Nutreco.
WuXi Diagnostics works out $150m series B
Strategic partner Thermo Fisher Scientific was among the participants in a series B round for the diagnostics technology producer.
Pocket Outdoor packs in $150m
Specialized Bicycle-backed Zone 5 Ventures was among the investors in a series B round announced in conjunction with the active media company's rebranding to Outside Media.

Other News

JG Summit calls Tyme for $110m round
JG Summit Holdings participated in a series B round for the digital banking network and will help it apply for a licence in the Philippines.
Sciwind swings $37m in series B
Legend Capital has returned to invest in the metabolic and immunological disease-focused biotechnology developer, having backed its series A round two years ago.
SPH stacks up $160m in series B
The JD.com, Shanghai Pharma and SoftBank China Venture Capital-backed O2O medical services operator, has secured fresh funding from investors including Sinocare.
Regor Therapeutics rakes in $90m
The Qilu Pharmaceutical-backed cancer, immune disorder and metabolic disease drug developer has closed a series B round led by Lilly Asia Ventures.
Elicio elevates series B to $73m
The Livzon-backed cancer and infectious disease therapy developer has added $40m to a round that will support the progression of its lead candidate toward clinical trials.
Corporate venturing deal net: 15-19 February 2021
Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

Editor's Picks

Intel spreads $72m across 12 companies
Intel Capital has revealed investments in 12 US or China-based portfolio companies and a partnership with the NBA.
Big Deal: Joby completes $100m funding job
Joby Aviation has raised $100m in an Intel Capital-led series B round that included JetBlue Technology Ventures, indicating the rise in air-based corporate venturing.
Huochebang loads up another $156m
Baidu Capital, which has just appointed a CEO, has co-led the logistics platform's series B-2 round, adding to a $115m tranche co-led by Tencent in December.
Big Deal: Corporates find Unity
Unity Biotechnology, which raised $116m last week, is the fourth Arch Venture Partners-launched startup to be backed by WuXi PharmaTech.
test reg

Login